Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotarix Immunogenicity at Varying Schedules in Rural Ghana
NCT01575197Phase 4Completed
- Sponsor
- PATH
- Start
- Sep 2012
- Primary completion
- Feb 2013
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised trial of human rotavirus RIX4414 strain vaccine in rotavirus gastroenteritis (3 arms), sponsored by PATH. Primary endpoint: Immunoglobulin A (IgA) Seroconversion. Started Sep 2012; status: completed.
02
Drugs
human rotavirus RIX4414 strain vaccine
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT01575197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01575197.